Literature DB >> 30314758

Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus.

Scott A Jenks1, Kevin S Cashman1, Esther Zumaquero2, Urko M Marigorta3, Aakash V Patel1, Xiaoqian Wang1, Deepak Tomar1, Matthew C Woodruff1, Zoe Simon1, Regina Bugrovsky1, Emily L Blalock1, Christopher D Scharer4, Christopher M Tipton1, Chungwen Wei1, S Sam Lim1, Michelle Petri5, Timothy B Niewold6, Jennifer H Anolik7, Greg Gibson3, F Eun-Hyung Lee8, Jeremy M Boss4, Frances E Lund2, Ignacio Sanz9.   

Abstract

Systemic Lupus Erythematosus (SLE) is characterized by B cells lacking IgD and CD27 (double negative; DN). We show that DN cell expansions reflected a subset of CXCR5- CD11c+ cells (DN2) representing pre-plasma cells (PC). DN2 cells predominated in African-American patients with active disease and nephritis, anti-Smith and anti-RNA autoantibodies. They expressed a T-bet transcriptional network; increased Toll-like receptor-7 (TLR7); lacked the negative TLR regulator TRAF5; and were hyper-responsive to TLR7. DN2 cells shared with activated naive cells (aNAV), phenotypic and functional features, and similar transcriptomes. Their PC differentiation and autoantibody production was driven by TLR7 in an interleukin-21 (IL-21)-mediated fashion. An in vivo developmental link between aNAV, DN2 cells, and PC was demonstrated by clonal sharing. This study defines a distinct differentiation fate of autoreactive naive B cells into PC precursors with hyper-responsiveness to innate stimuli, as well as establishes prominence of extra-follicular B cell activation in SLE, and identifies therapeutic targets.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoimmunity; CD11c; Systemic Lupus Erythematous; T-bet; TRAF5; Toll-like receptor 7; effector; human B cells; plasma cells

Mesh:

Substances:

Year:  2018        PMID: 30314758      PMCID: PMC6217820          DOI: 10.1016/j.immuni.2018.08.015

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  49 in total

Review 1.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

2.  Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients.

Authors:  Rafah Salloum; Beverly S Franek; Silvia N Kariuki; Lesley Rhee; Rachel A Mikolaitis; Meenakshi Jolly; Tammy O Utset; Timothy B Niewold
Journal:  Arthritis Rheum       Date:  2010-02

3.  Repression of the transcription factor Bach2 contributes to predisposition of IgG1 memory B cells toward plasma cell differentiation.

Authors:  Kohei Kometani; Rinako Nakagawa; Ryo Shinnakasu; Tomohiro Kaji; Andrei Rybouchkin; Saya Moriyama; Koji Furukawa; Haruhiko Koseki; Toshitada Takemori; Tomohiro Kurosaki
Journal:  Immunity       Date:  2013-07-11       Impact factor: 31.745

4.  A balance between B cell receptor and inhibitory receptor signaling controls plasma cell differentiation by maintaining optimal Ets1 levels.

Authors:  Anne B Satterthwaite; Wei Luo; Jessica Mayeux; Toni Gutierrez; Lisa Russell; Andrew Getahun; Jennifer Müller; Thomas Tedder; Jane Parnes; Robert Rickert; Lars Nitschke; John Cambier; Lee Ann Garrett-Sinha
Journal:  J Immunol       Date:  2014-06-13       Impact factor: 5.422

5.  Opposing impact of B cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation.

Authors:  Shaun W Jackson; Nicole E Scharping; Nikita S Kolhatkar; Socheath Khim; Marc A Schwartz; Quan-Zhen Li; Kelly L Hudkins; Charles E Alpers; Denny Liggitt; David J Rawlings
Journal:  J Immunol       Date:  2014-04-07       Impact factor: 5.422

6.  Identification of IgG subclasses and C-reactive protein in lupus nephritis: the relationship between the composition of immune deposits and FCgamma receptor type IIA alleles.

Authors:  Ricardo Zuniga; Glen S Markowitz; Thaschawee Arkachaisri; Edward A Imperatore; Vivette D D'Agati; Jane E Salmon
Journal:  Arthritis Rheum       Date:  2003-02

7.  CD11c expression identifies a population of extrafollicular antigen-specific splenic plasmablasts responsible for CD4 T-independent antibody responses during intracellular bacterial infection.

Authors:  Rachael Racine; Madhumouli Chatterjee; Gary M Winslow
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

8.  ATAC-seq on biobanked specimens defines a unique chromatin accessibility structure in naïve SLE B cells.

Authors:  Christopher D Scharer; Emily L Blalock; Benjamin G Barwick; Robert R Haines; Chungwen Wei; Ignacio Sanz; Jeremy M Boss
Journal:  Sci Rep       Date:  2016-06-01       Impact factor: 4.379

9.  Expression of FcRL4 defines a pro-inflammatory, RANKL-producing B cell subset in rheumatoid arthritis.

Authors:  L Yeo; H Lom; M Juarez; M Snow; C D Buckley; A Filer; K Raza; D Scheel-Toellner
Journal:  Ann Rheum Dis       Date:  2014-01-15       Impact factor: 19.103

10.  Interferon (IFN)-λ is a potential mediator in lupus nephritis.

Authors:  Agneta Zickert; Vilija Oke; Ioannis Parodis; Elisabet Svenungsson; Yvonne Sundström; Iva Gunnarsson
Journal:  Lupus Sci Med       Date:  2016-11-22
View more
  238 in total

1.  IL-23 Promotes a Coordinated B Cell Germinal Center Program for Class-Switch Recombination to IgG2b in BXD2 Mice.

Authors:  Huixian Hong; Min Gao; Qi Wu; PingAr Yang; Shanrun Liu; Hao Li; Peter D Burrows; Daniel Cua; Jake Y Chen; Hui-Chen Hsu; John D Mountz
Journal:  J Immunol       Date:  2020-06-17       Impact factor: 5.422

Review 2.  Innate B Cells: the Archetype of Protective Immune Cells.

Authors:  Alexis Grasseau; Marina Boudigou; Laëtitia Le Pottier; Nedra Chriti; Divi Cornec; Jacques-Olivier Pers; Yves Renaudineau; Sophie Hillion
Journal:  Clin Rev Allergy Immunol       Date:  2020-02       Impact factor: 8.667

Review 3.  Autoimmunity and organ damage in systemic lupus erythematosus.

Authors:  George C Tsokos
Journal:  Nat Immunol       Date:  2020-05-04       Impact factor: 25.606

Review 4.  Design and application of single-cell RNA sequencing to study kidney immune cells in lupus nephritis.

Authors:  Deepak A Rao; Arnon Arazi; David Wofsy; Betty Diamond
Journal:  Nat Rev Nephrol       Date:  2019-12-18       Impact factor: 28.314

Review 5.  The Post-GWAS Era: How to Validate the Contribution of Gene Variants in Lupus.

Authors:  Adam J Fike; Irina Elcheva; Ziaur S M Rahman
Journal:  Curr Rheumatol Rep       Date:  2019-01-23       Impact factor: 4.592

Review 6.  BAFF inhibition in SLE-Is tolerance restored?

Authors:  Shaun W Jackson; Anne Davidson
Journal:  Immunol Rev       Date:  2019-09-28       Impact factor: 12.988

Review 7.  B-cell abnormalities in HIV-1 infection: roles for IgG3 and T-bet.

Authors:  Lela Kardava; Susan Moir
Journal:  Curr Opin HIV AIDS       Date:  2019-07       Impact factor: 4.283

8.  Overexpression of T-bet in HIV infection is associated with accumulation of B cells outside germinal centers and poor affinity maturation.

Authors:  James W Austin; Clarisa M Buckner; Lela Kardava; Wei Wang; Xiaozhen Zhang; Valerie A Melson; Ryan G Swanson; Andrew J Martins; Julian Q Zhou; Kenneth B Hoehn; J Nicholas Fisk; Yiannis Dimopoulos; Alexander Chassiakos; Sijy O'Dell; Margery G Smelkinson; Catherine A Seamon; Richard W Kwan; Michael C Sneller; Stefania Pittaluga; Nicole A Doria-Rose; Adrian McDermott; Yuxing Li; Tae-Wook Chun; Steven H Kleinstein; John S Tsang; Constantinos Petrovas; Susan Moir
Journal:  Sci Transl Med       Date:  2019-11-27       Impact factor: 17.956

9.  PIK3IP1 Promotes Extrafollicular Class Switching in T-Dependent Immune Responses.

Authors:  Kristina Ottens; Jalyn Schneider; Lawrence P Kane; Anne B Satterthwaite
Journal:  J Immunol       Date:  2020-09-04       Impact factor: 5.422

10.  OMIP-068: High-Dimensional Characterization of Global and Antigen-Specific B Cells in Chronic Infection.

Authors:  Katherine Cascino; Mario Roederer; Thomas Liechti
Journal:  Cytometry A       Date:  2020-08-28       Impact factor: 4.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.